Monique Brown, MD
General Practice · Rocky Mount, NCNPI 1336289636
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 501 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Among general practice clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 501 payments — averaging $19.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Teva Pharmaceuticals USA, Inc.$1K
- Alkermes, Inc.$962
- Otsuka America Pharmaceutical, Inc.$872
- Neurocrine Biosciences, Inc.$724
- Sunovion Pharmaceuticals Inc.$598
- plus $4K from 26 others
What the payments were for
- Food & beverage$9,758100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 120 | $1,476 |
| Teva Pharmaceuticals USA, Inc. | 62 | $1,173 |
| Alkermes, Inc. | 44 | $962 |
| Otsuka America Pharmaceutical, Inc. | 31 | $872 |
| Neurocrine Biosciences, Inc. | 28 | $724 |
| Sunovion Pharmaceuticals Inc. | 30 | $598 |
| Ironshore Pharmaceuticals Inc. | 26 | $513 |
| Tris Pharma Inc | 24 | $412 |
| Corium, LLC | 18 | $378 |
| Supernus Pharmaceuticals, Inc. | 20 | $344 |
| Johnson & Johnson | 10 | $251 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $235 |
| Axsome Therapeutics, Inc. | 6 | $232 |
| E.r. Squibb & Sons, L.L.C. | 6 | $225 |
| AstraZeneca | 5 | $188 |
| Vanda Pharmaceuticals Inc. | 8 | $171 |
| Idorsia Pharmaceuticals US Inc | 1 | $125 |
| Adlon Therapeutics L.p. | 7 | $122 |
| Vertical Pharmaceuticals, LLC | 6 | $97 |
| Lundbeck LLC | 4 | $91 |
| Neos Therapeutics, LP | 6 | $86 |
| Novo Nordisk | 4 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $69 |
| Rhodes Pharmaceuticals L.p. | 5 | $61 |
| Shire North American Group Inc | 4 | $61 |
| Pfizer | 3 | $54 |
| Collegium Pharmaceutical, Inc. | 3 | $47 |
| Lilly USA, LLC | 2 | $43 |
| Ardelyx, Inc. | 1 | $21 |
| Almatica Pharma LLC | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,758 in reported general payments places this provider in the 95th percentile of 2,924 general practice providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 21 | $229,029 |
| IngrezzaValbenazine Tosylate | 20 | $194,282 |
| RexultiBrexpiprazole | 49 | $75,472 |
| Invega SustennaPaliperidone Palmitate | 17 | $64,435 |
| Abilify MaintenaAripiprazole | 16 | $44,531 |
| AristadaAripiprazole Lauroxil | 13 | $39,817 |
| VraylarCariprazine Hcl | 11 | $26,484 |
| LinzessLinaclotide | 28 | $17,738 |
| TrulicityDulaglutide | 18 | $17,177 |
| FarxigaDapagliflozin Propanediol | 21 | $12,106 |
| BelsomraSuvorexant | 23 | $10,871 |
| VyvanseLisdexamfetamine Dimesylate | 14 | $5,876 |
| Atomoxetine Hcl | 74 | $5,209 |
| JanumetSitagliptin Phos/Metformin Hcl | 12 | $3,527 |
| Paliperidone ErPaliperidone | 29 | $3,515 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo | $1,173 | $229,02921 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $724 | $194,28220 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena | $872 | $120,00365 claims |
| Johnson & JohnsonInvega Sustenna | $251 | $64,43517 claims |
| AbbVieVraylar, Linzess | $1,476 | $44,22239 claims |
| Alkermes, Inc.Aristada | $962 | $39,81713 claims |
| Lilly USA, LLCTrulicity | $43 | $17,17718 claims |
| AstraZenecaFarxiga | $188 | $12,10621 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $69 | $5,87614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,924 general practice providers in North Carolina.
Other general practice in Rocky Mount
- Lois WilkinsonRocky Mount$26K
- Matthew MillerCharlotte$937K
- James BarberDurham$768K
- Robert LoweCharlotte$615K
- Clifton CameronFayetteville$404K
- Leo HaydtHolly Springs$119K
- Andrew KellyGreensboro$115K
- Mark HymanGreensboro$95K
- Jesse ClarkWilmington$91K
- Adam HodgesAsheville$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.